MarketInOut Stock Screener Log In | Sign Up
 

Generate Biomedicines Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026 16:00
Generate Biomedicines Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,565.9 mln
Float55.21 mln
Earnings Date11/05/2026

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-952%
Severely loss-making

ROE

-26.51
Deeply negative

Altman Z-Score

9.3
Exceptional

ROA

-21.68
Deeply negative

Business Description

Generate Biomedicines is a biotechnology company based in Somerville, Massachusetts, that uses machine learning to design and develop new protein-based medicines. The company is advancing several drug candidates, including treatments targeting severe asthma, cancer, and other serious conditions. Its proprietary platform combines advanced computing with laboratory technology to create therapies that would be difficult or impossible to develop using conventional methods. Founded in 2018, the company aims to push the boundaries of what modern medicine can achieve.

Key Fundamentals

EPS-2.44
ROE-26.51
RPS0.32
ROIC-106
ROA-21.68
Interest Cover-304
EBITDA, mln-122
EV / EBITDA-12.62
EV / EBIT-11.99
Revenue, mln13.54
EV / Revenue114

Quote Details

Last 12.41
Change -0.38 (-2.97%)
Open 12.75
Volume 295,554
Turnover 3,667,825
Average Volume 935,934

Financial Ratios

Pre-Tax Profit Margin-952
Leverage Ratio1.23
Current Ratio8.30
Price / Book4.24
Price / Tangible Book4.24
Debt / Equity0.14
Price / Sales144

Financial Strength

Altman Z-Score9.3
Short Ratio6.27
Short % of Float9.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.65% 82 / 100   
1 Month -22.39% 16 / 100   
2 Months -8.62% 34 / 100   
6 Months -3.05% 44 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog